Mikyoung You

Dr. Mikyoung You


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
YLYoung-Hyun Lee
Young-Hyun Lee
MYMikyoung You
Mikyoung You
HKHyeon-A Kim
Hyeon-A Kim
Background/Objectives: Obesity is a significant global health concern, and the natural bioactive compounds with anti-obesity effects remain challenging. This study aims to examine the anti-obesity effect and the potential mechanism of Vaccinium oldhamii fruit water extract (VOW). Methods: Lipid accumulation, AMP-activated protein kinase (AMPK) activity, and Wnt/β-catenin signaling were evaluated in 3T3-L1 cells. In high-fat and high-sucrose diet (HFHSD)-induced obese mice, body weight, food intake, fat weight, serum lipid profiles, and adipogenic transcription factors were assessed. The most effective VOW fraction was selected by Oil Red O (ORO) staining and its mechanism was studied in 3T3-L1 cells. Results: VOW treatment significantly inhibited cellular lipid accumulation and suppressed phosphorylation of AMPK and its downstream protein, acetyl-CoA carboxylase (ACC). VOW also decreased adipogenic-associated protein expressions such as the peroxisome proliferator-activated receptor-γ (PPAR-γ), CCAAT/enhancer-binding proteins α (C/EBP α), sterol regulatory element binding protein-1c (SREBP-1c), and fatty acid synthase (FAS). The enhanced effect of VOW was abolished by the knockdown of AMPK with siRNA. The inhibitory effect of VOW on differentiation depended on the treatment period, even though VOW treatment downregulated the C/EBP β expression at the early phase of differentiation. VOW dramatically reduced activation of AMPK, thereby downregulating adipogenic-associated proteins. Furthermore, the butanol fraction (BtOH) of VOW showed the most powerful effect of VOW dose-dependently reduced lipid accumulation by suppressing the phosphorylation of AMPK. Consistent with inhibited lipid accumulation in vitro, VOW reduced body weight and white adipose tissue weight in the HFHSD-induced obese animal model. Conclusions: Overall, our study suggested that the anti-adipogenesis effect of VOW and its BtOH fraction involved the activation of AMPK.

Verified
Journal Article
Open access
PDF file
MYMikyoung You
Mikyoung You
SCSoonkyu Chung
Soonkyu Chung
Iron regulatory receptor 1 (IRP1) plays a key regulatory role in iron homeostasis, hypoxia sensing, and erythropoiesis. IRP1 deficiency causes polycythemia in early life, which is worsened by a low-iron diet. A high-fat (HF) diet is a prevalent metabolic insult that causes local hypoxia in adipose tissue, but little is known about the role of IRP1-mediated metabolic adjustments in preserving iron balance. In this study, we hypothesized that deletion of IRP1 fails to control HF-diet-induced hypoxia, thereby exacerbating diet-induced obesity and insulin resistance. HF feeding in IRP1-deficient mice induced a dramatic increase in EPO production, aberrant erythropoiesis, and splenomegaly through the reinstatement of the HIF2 α/EPO pathway. The deletion of IRP1 did not alter body weight gain but caused a paradoxical increase in glucose tolerance compared with WT mice. The 2-DOG uptake assay showed higher RBC-associated radioactivity in IRP1-deficient mice. RBC metabolomic analysis further demonstrated that IRP1 deficiency is associated with elevated metabolite levels generated by glycolysis and the pentose phosphate pathway. Collectively, our work demonstrates that IRP1 plays a critical role in preventing abnormal RBC formation under HF diet-mediated hypoxic conditions. Our work also provides an unexpected insight into RBC metabolism as a novel target against insulin resistance.